Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy
Clinically Node Negative Breast Cancer Patients Undergoing Breast Conserving Therapy: Sentinel Lymph Node Procedure Versus Follow-Up.
Sponsor: Borstkanker Onderzoek Groep
This NA trial investigates Breast Neoplasms and is currently ongoing. Borstkanker Onderzoek Groep leads this study, which shows 10 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Jan 2026 — Present [monthly]
Active Not Recruiting NA
-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Jun 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Jun 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2021 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE3 → NA
-
Apr 2017 — May 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE3
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Borstkanker Onderzoek Groep
- Dutch Cancer Society
- Maastricht University
- Maastricht University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .